Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles
International Journal of Molecular Sciences · 15.07.2023 · 24 (14) · 11520
DOI: 10.3390/ijms241411520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2023. Verfasst von Shudong Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Muscular Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College London, UCL Global Engagement Fund, Fellowship Incubator Awards.
Abstract (Originalsprache)
Skeletal muscle, which comprises a significant portion of the body, is responsible for vital functions such as movement, metabolism, and overall health. However, severe injuries often result in volumetric muscle loss (VML) and compromise the regenerative capacity of the muscle. Tissue-engineered muscles offer a potential solution to address lost or damaged muscle tissue, thereby restoring muscle function and improving patients’ quality of life. Induced pluripotent stem cells (iPSCs) have emerged as a valuable cell source for muscle tissue engineering due to their pluripotency and self-renewal capacity, enabling the construction of tissue-engineered artificial skeletal muscles with applications in transplantation, disease modelling, and bio-hybrid robots. Next-generation iPSC-based models have the potential to revolutionize drug discovery by offering personalized muscle cells for testing, reducing reliance on animal models. This review provides a comprehensive overview of iPSCs in tissue-engineered artificial skeletal muscles, highlighting the advancements, applications, advantages, and challenges for clinical translation. We also discussed overcoming limitations and considerations in differentiation protocols, characterization methods, large-scale production, and translational regulations. By tackling these challenges, iPSCs can unlock transformative advancements in muscle tissue engineering and therapeutic interventions for the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgery and Interventional Science, University College London, London NW3 2QG, UK.
- Department of iPS Cell Applications, Kobe University, Kobe 657-8501, Japan.
ORCID-Profile: Jishizhan Chen, Lei Wu, Jinke Chang
Förderung
- University College London
- UCL Global Engagement Fund
- Fellowship Incubator Awards
Zitieren
APA
Zhao, S., Chen, J., Wu, L., Tao, X., Yaqub, N., & Chang, J. (2023). Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles. International Journal of Molecular Sciences, 24(14), 11520. https://doi.org/10.3390/ijms241411520
Vancouver
Zhao S, Chen J, Wu L, Tao X, Yaqub N, Chang J. Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles. International Journal of Molecular Sciences. 2023;24(14):11520. doi:10.3390/ijms241411520
BibTeX
@article{Zhao2023,
author = {Zhao, Shudong and Chen, Jishizhan and Wu, Lei and Tao, Xin and Yaqub, Naheem and Chang, Jinke},
title = {Induced Pluripotent Stem Cells for Tissue-Engineered Skeletal Muscles},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {14},
pages = {11520},
doi = {10.3390/ijms241411520}
}
EUVIMED